Moleculin Biotech Inc (NASDAQ: MBRX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it will be holding a conference call to discuss a recent discovery in the potential treatment of lung cancer.
As you could imagine, the news excited investors, pushing the stock on a run for the top. Today, we’ll talk about:
- The coming conference call;
- what we’re seeing from MBRX stock as a result; and
- what we’ll be watching for ahead.
MBRX Announces Coming Conference Call
As mentioned above, Moleculin Biotech is having a great day in the market today after announcing a coming conference. The announcement came via press release early in the pre-market hours this morning.
In the release, the company said that it will host a conference call on Wednesday, April 24, 2019, at 4:30 ET. During the conference call, MBRX said that it will discuss a significant discovery in lung cancer, an FDA Fast Track Designation, and recent corporate events.
For those that would like to take part in the call, you can do so using the following information:
- Dian In Phone Numbers – (800) 860-2442 or (412) 858-4600.
- Webcast – You can also visit the conference via webcast by navigating to the Investor Relations section of the company’s website at www.moleculin.com.
- Replay – Finally, a replay will be provided on the company’s website and by calling either (877) 344-7529 or (412) 317-0088 and using the confirmation code 10130980.
In the release, the company also said that it will be taking questions in the Q&A segment. Please send your questions in advance to firstname.lastname@example.org.
What We’re Seeing From The Stock
One of the first lessons that we learn when we start to work in the market is that the news leads to moves. When it comes to Moleculin Biotech, the news proved to be overwhelmingly positive.
After the recent announcement of the lung cancer discovery, investors are looking for more information. Knowing that this is coming, along with a Fast Track Designation update and corporate update seems to be leading to quite a bit of excitement.
So, it’s not surprising to see that the stock is headed up. As is just about always the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (9:46), MBRX is trading at $1.38 per share after a gain of $0.27 per share or 24.32% thus far today.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on MBRX. In particular, we’re interested in following the story surrounding the company’s continued work to provide value to shareholders and develop the products within its pipeline. Nonetheless, we’ll keep a close eye on the news and bring it to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!